{
    "eid": "2-s2.0-85111558326",
    "title": "A phase 2 study of nilotinib in pediatric patients with CML: Long-term update on growth retardation and safety",
    "cover-date": "2021-07-27",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "Nobuko Hijiya",
        "Alexey Maschan",
        "Carmelo Rizzari",
        "Hiroyuki Shimada",
        "Carlo Dufour",
        "Hiroaki Goto",
        "Hyoung Jin Kang",
        "Terri Guinipero",
        "Zeynep Karakas",
        "Francisco Bautista",
        "Stephane Ducassou",
        "Keon Hee Yoo",
        "Christian Michel Zwaan",
        "Frederic Millot",
        "Briana Patterson",
        "Jill Samis",
        "Paola Aimone",
        "Alex Allepuz",
        "Ksenia Titorenko",
        "Darintr Sosothikul"
    ],
    "citedby-count": 6,
    "ref-count": 31,
    "ref-list": [
        "Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group",
        "How I treat chronic myeloid leukemia in children and adolescents",
        "Dasatinib in pediatric patients with chronic myeloid leukemia in chronic phase: results from a phase II trial",
        "Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia",
        "Recognizing endocrinopathies associated with tyrosine kinase inhibitor therapy in children with chronic myelogenous leukemia",
        "Pediatric chronic myeloid leukemia is a unique disease that requires a different approach",
        "Imatinib is effective in children with previously untreated chronic myelogenous leukemia in early chronic phase: results of the French national phase IV trial",
        "Long-term results of high-dose imatinib in children and adolescents with chronic myeloid leukaemia in chronic phase: the Italian experience",
        "Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial",
        "Growth deceleration in children treated with imatinib for chronic myeloid leukaemia",
        "Growth disturbances in children and adolescents receiving long-term tyrosine kinase inhibitor therapy for chronic myeloid leukaemia or philadelphia chromosome-positive acute lymphoblastic leukaemia",
        "Distinct impact of imatinib on growth at prepubertal and pubertal ages of children with chronic myeloid leukemia",
        "The small problem when treating childhood chronic myeloid leukemia",
        "Growth rate and endocrine effects of dasatinib therapy observed in a retrospective analysis of a phase 2 clinical trial for pediatric patients with chronic myeloid leukemia in chronic phase",
        "Pharmacokinetics of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia or acute lymphoblastic leukemia",
        "A phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia: safety update after 36 cycles of treatment",
        "Variations in pattern of pubertal changes in girls",
        "Variations in the pattern of pubertal changes in boys",
        "Hy's law: predicting serious hepatotoxicity",
        "Outcomes of allogeneic hematopoietic cell transplantation in children and young adults with chronic myeloid leukemia: a CIBMTR cohort analysis",
        "Evaluating the endometabolic and bone health effects of tyrosine kinase inhibitors in chronic myeloid leukaemia: a systematic review protocol",
        "Impact of tyrosine kinase inhibitors on the statural growth in children with acute lymphoblastic leukemia",
        "Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial",
        "Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results",
        "Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial",
        "Tyrosine kinase inhibitor-associated cardiovascular toxicity in chronic myeloid leukemia"
    ],
    "affiliation": [
        {
            "affiliation-city": "Utrecht",
            "@id": "60273130",
            "affilname": "Princess M\u00e1xima Center for Pediatric Oncology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60273130",
            "affiliation-country": "Netherlands"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60120717",
            "affilname": "Seoul National University Children's Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60120717",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "New York",
            "@id": "60027565",
            "affilname": "Columbia University Irving Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027565",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Madrid",
            "@id": "60026312",
            "affilname": "Hospital Infantil Universitario Ni\u00f1o Jes\u00fas",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026312",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "Yokohama",
            "@id": "60025326",
            "affilname": "Kanagawa Children's Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025326",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Tokyo",
            "@id": "60025252",
            "affilname": "Keio University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025252",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Poitiers",
            "@id": "60020859",
            "affilname": "Centre Hospitalier Universitaire de Poitiers",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020859",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Chicago IL",
            "@id": "60017031",
            "affilname": "Ann &amp; Robert H. Lurie Children's Hospital of Chicago",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017031",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Suwon",
            "@id": "60016329",
            "affilname": "SKKU School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016329",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Genoa",
            "@id": "60016041",
            "affilname": "Istituto Giannina Gaslini",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016041",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Rotterdam",
            "@id": "60015627",
            "affilname": "Erasmus MC Sophia Children's Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015627",
            "affiliation-country": "Netherlands"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60013682",
            "affilname": "Seoul National University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013682",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Istanbul",
            "@id": "60012324",
            "affilname": "\u0130stanbul T\u0131p Fak\u00fcltesi",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012324",
            "affiliation-country": "Turkey"
        },
        {
            "affiliation-city": "Milan",
            "@id": "60012306",
            "affilname": "Universit\u00e0 degli Studi di Milano-Bicocca",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012306",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Basel",
            "@id": "60009968",
            "affilname": "Novartis International AG",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009968",
            "affiliation-country": "Switzerland"
        },
        {
            "affiliation-city": "Columbus",
            "@id": "60003500",
            "affilname": "The Ohio State University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60003500",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bordeaux",
            "@id": "60003362",
            "affilname": "Groupe Hospitalier Pellegrin",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60003362",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Atlanta",
            "@id": "60002339",
            "affilname": "Emory University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002339",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60000656",
            "affilname": "Seoul National University College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000656",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Hongcheon-gun",
            "@id": "126654722",
            "affilname": "Wide River Institute of Immunology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126654722",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": null,
            "@id": "126654222",
            "affilname": "Innovative Therapies for Children with Cancer (ITCC) Consortium",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126654222",
            "affiliation-country": "Netherlands"
        },
        {
            "affiliation-city": "Moscow",
            "@id": "117733206",
            "affilname": "Novartis Pharma LLC",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/117733206",
            "affiliation-country": "Russian Federation"
        },
        {
            "affiliation-city": "Moscow",
            "@id": "113139706",
            "affilname": "Dmitriy Rogachev National Center for Pediatric Hematology, Oncology and Immunology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/113139706",
            "affiliation-country": "Russian Federation"
        }
    ],
    "funding": []
}